AGM Statement

AI SummaryClose X

CelLBxHealth plc provided an AGM statement confirming that fundamental business aspects remain unchanged and the commercial opportunity is significant, with a focus on disciplined execution and revenue growth. The company is on track to deliver revenues for FY 2026 of at least £2.1 million, representing a 50% increase over FY 2025. The Executive Chairman will continue in his role, and the company is confident in its senior leadership team's capacity during the search for a new Chief Executive Officer, with recruitment already underway.

Disclaimer*

UK 100

Latest directors dealings